Skip to main content
Top
Published in:

Open Access 10-03-2025 | Giant Cell Arteritis | Case Report

Aseptic meningitis in the setting of giant cell arteritis (GCA): a case report

Authors: Lehashenee Thirukumar, Robin Sia, Justin Jackson, John Burston

Published in: BMC Rheumatology | Issue 1/2025

Login to get access

Abstract

Background

Giant cell arteritis (GCA) is a vasculitis primarily affecting medium- and large-sized arteries. The diagnosis may be challenging and lead to delays in treatment. Cerebrospinal fluid (CSF) pleocytosis is an uncommon association but may occur due to central nervous system (CNS) vasculitis or pachymeningitis. We describe a case fulfilling the criteria for diagnosing GCA, associated with CSF pleocytosis and normal neuroimaging.

Case presentation

A 76-year-old woman presented to our regional hospital with three weeks of fever, confusion and fatigue. Two days later, she developed a right temporal headache with scalp tenderness. Preliminary investigations, including an FDG-PET scan, were unrevealing. Cerebrospinal fluid sampling demonstrated an isolated mononuclear pleocytosis. Brain magnetic resonance imaging (MRI) and an extensive panel of investigations failed to identify a cause, and a diagnosis of aseptic meningitis was made. An ultrasound of her right temporal artery was performed which demonstrated a non-compressible halo sign consistent with GCA. The patient was commenced on high-dose corticosteroid therapy with significant improvement in her symptoms.

Conclusions

This case strengthens the association of CSF pleocytosis occurring as a complication of GCA and alerts clinicians to consider the possibility of GCA as a potential aetiology for aseptic meningitis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tapiainen T, Prevots R, Izurieta HS, Abramson J, Bilynsky R, Bonhoeffer J, et al. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine. 2007;25(31):5793–802.CrossRefPubMed Tapiainen T, Prevots R, Izurieta HS, Abramson J, Bilynsky R, Bonhoeffer J, et al. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine. 2007;25(31):5793–802.CrossRefPubMed
2.
go back to reference Shukla B, Aguilera EA, Salazar L, Wootton SH, Kaewpoowat Q, Hasbun R. Aseptic meningitis in adults and children: diagnostic and management challenges. J Clin Virol. 2017;94:110–4.CrossRefPubMedPubMedCentral Shukla B, Aguilera EA, Salazar L, Wootton SH, Kaewpoowat Q, Hasbun R. Aseptic meningitis in adults and children: diagnostic and management challenges. J Clin Virol. 2017;94:110–4.CrossRefPubMedPubMedCentral
3.
go back to reference Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American college of rheumatology/eular classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):1647.CrossRefPubMed Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American college of rheumatology/eular classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):1647.CrossRefPubMed
4.
go back to reference Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology. 2017;56(4):506–15.PubMed Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology. 2017;56(4):506–15.PubMed
5.
go back to reference Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound cut-off values for intima-media thickness of Temporal, facial and axillary arteries in giant cell arteritis. Rheumatology. 2017;56(9):1479–83.CrossRefPubMed Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound cut-off values for intima-media thickness of Temporal, facial and axillary arteries in giant cell arteritis. Rheumatology. 2017;56(9):1479–83.CrossRefPubMed
6.
go back to reference Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024;83(6):741.CrossRefPubMed Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024;83(6):741.CrossRefPubMed
7.
go back to reference Bosch P, Bond M, Dejaco C, Ponte C, Mackie SL, Falzon L, et al. Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open. 2023;9(3):e003379.CrossRefPubMedPubMedCentral Bosch P, Bond M, Dejaco C, Ponte C, Mackie SL, Falzon L, et al. Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open. 2023;9(3):e003379.CrossRefPubMedPubMedCentral
8.
go back to reference Nielsen BD, Hansen IT, Keller KK, Therkildsen P, Gormsen LC, Hauge E-M. Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference. Rheumatology. 2019;59(8):2062–73.CrossRef Nielsen BD, Hansen IT, Keller KK, Therkildsen P, Gormsen LC, Hauge E-M. Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference. Rheumatology. 2019;59(8):2062–73.CrossRef
9.
go back to reference Rahman W, Rahman FZ. Giant cell (Temporal) arteritis: an overview and update. Surv Ophthalmol. 2005;50(5):415–28.CrossRefPubMed Rahman W, Rahman FZ. Giant cell (Temporal) arteritis: an overview and update. Surv Ophthalmol. 2005;50(5):415–28.CrossRefPubMed
11.
go back to reference Hirsch M, Mayersdorf A, Lehmann E. Cranial giant-cell arteritis. Br J Radiol. 1974;47(560):503–6.CrossRefPubMed Hirsch M, Mayersdorf A, Lehmann E. Cranial giant-cell arteritis. Br J Radiol. 1974;47(560):503–6.CrossRefPubMed
12.
go back to reference Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum. 2006;55(6):985–9.CrossRefPubMed Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum. 2006;55(6):985–9.CrossRefPubMed
13.
go back to reference Larivière D, Sacre K, Klein I, Hyafil F, Choudat L, Chauveheid M-P, et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study. Medicine. 2014;93(28). Larivière D, Sacre K, Klein I, Hyafil F, Choudat L, Chauveheid M-P, et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study. Medicine. 2014;93(28).
14.
go back to reference Parra J, Domingues J, Sargento-Freitas J, Santana I. Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis. BMJ Case Rep. 2014;2014. Parra J, Domingues J, Sargento-Freitas J, Santana I. Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis. BMJ Case Rep. 2014;2014.
15.
go back to reference Beuker C, Wankner MC, Thomas C, Strecker J-K, Schmidt-Pogoda A, Schwindt W, et al. Characterization of extracranial giant cell arteritis with intracranial involvement and its rapidly progressive subtype. Ann Neurol. 2021;90(1):118–29.CrossRefPubMed Beuker C, Wankner MC, Thomas C, Strecker J-K, Schmidt-Pogoda A, Schwindt W, et al. Characterization of extracranial giant cell arteritis with intracranial involvement and its rapidly progressive subtype. Ann Neurol. 2021;90(1):118–29.CrossRefPubMed
16.
go back to reference Gordon M, Gordon EP. Temporal arteritis: cerebrospinal fluid and brain scan abnormalities (Case Report). J Am Geriatr Soc. 1980;28(3):136–8.CrossRefPubMed Gordon M, Gordon EP. Temporal arteritis: cerebrospinal fluid and brain scan abnormalities (Case Report). J Am Geriatr Soc. 1980;28(3):136–8.CrossRefPubMed
17.
go back to reference Hirohata S, Tanimoto K, Ito K. Elevation of cerebrospinal fluid Interleukin-6 activity in patients with vasculitides and central nervous system involvement. Clin Immunol Immunopathol. 1993;66(3):225–9.CrossRefPubMed Hirohata S, Tanimoto K, Ito K. Elevation of cerebrospinal fluid Interleukin-6 activity in patients with vasculitides and central nervous system involvement. Clin Immunol Immunopathol. 1993;66(3):225–9.CrossRefPubMed
18.
go back to reference Roelcke U, Eschle D, Kappos L, Moschopulos M, Laeng RH, Buettner UW. Meningoradiculitis associated with giant cell arteritis. Neurology. 2002;59(11):1811–2.CrossRefPubMed Roelcke U, Eschle D, Kappos L, Moschopulos M, Laeng RH, Buettner UW. Meningoradiculitis associated with giant cell arteritis. Neurology. 2002;59(11):1811–2.CrossRefPubMed
19.
go back to reference Boisch G, Duda S, Hartmann C, Weßling H. Hypertrophic pachymeningoencephalitis associated with temporal giant cell arteritis. BMJ Case Rep. 2018;2018. Boisch G, Duda S, Hartmann C, Weßling H. Hypertrophic pachymeningoencephalitis associated with temporal giant cell arteritis. BMJ Case Rep. 2018;2018.
20.
go back to reference Kutty RK, Maekawa M, Kawase T, Fujii N, Kato Y. Temporal arteritis with focal pachymeningitis: a deceptive association. Nagoya J Med Sci. 2020;82(1):143–50.PubMedPubMedCentral Kutty RK, Maekawa M, Kawase T, Fujii N, Kato Y. Temporal arteritis with focal pachymeningitis: a deceptive association. Nagoya J Med Sci. 2020;82(1):143–50.PubMedPubMedCentral
21.
go back to reference Alonso A, Eisele P, Ebert AD, Griebe M, Engelhardt B, Szabo K, et al. Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis. Neurol Neuroimmunol Neuroinflammation. 2015;2(6):e164.CrossRef Alonso A, Eisele P, Ebert AD, Griebe M, Engelhardt B, Szabo K, et al. Leptomeningeal contrast enhancement and blood-CSF barrier dysfunction in aseptic meningitis. Neurol Neuroimmunol Neuroinflammation. 2015;2(6):e164.CrossRef
22.
go back to reference Watanabe R, Hashimoto M. Aging-Related vascular inflammation: giant cell arteritis and neurological disorders. Front Aging Neurosci. 2022;14. Watanabe R, Hashimoto M. Aging-Related vascular inflammation: giant cell arteritis and neurological disorders. Front Aging Neurosci. 2022;14.
23.
go back to reference Lahaye C, Sanchez M, Rouet A, Gross A, Faucher N, Raynaud-Simon A, et al. A curable pseudo-dementia related to an atypical presentation of giant cell arteritis. Age Ageing. 2020;49(3):487–9.CrossRefPubMed Lahaye C, Sanchez M, Rouet A, Gross A, Faucher N, Raynaud-Simon A, et al. A curable pseudo-dementia related to an atypical presentation of giant cell arteritis. Age Ageing. 2020;49(3):487–9.CrossRefPubMed
24.
go back to reference Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M. Stroke and Multi-Infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. Medicine. 2008;87(6). Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M. Stroke and Multi-Infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. Medicine. 2008;87(6).
25.
go back to reference Gunst J, Andersen H, Hjerrild S, Marinovskij E, Deutch S, Schembri A, et al. Neuropsychiatric symptoms among adult patients with aseptic meningitis: A prospective case series. Acta Psychiatrica Scandinavica. 2015;133. Gunst J, Andersen H, Hjerrild S, Marinovskij E, Deutch S, Schembri A, et al. Neuropsychiatric symptoms among adult patients with aseptic meningitis: A prospective case series. Acta Psychiatrica Scandinavica. 2015;133.
Metadata
Title
Aseptic meningitis in the setting of giant cell arteritis (GCA): a case report
Authors
Lehashenee Thirukumar
Robin Sia
Justin Jackson
John Burston
Publication date
10-03-2025
Publisher
BioMed Central
Published in
BMC Rheumatology / Issue 1/2025
Electronic ISSN: 2520-1026
DOI
https://doi.org/10.1186/s41927-025-00480-4

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more